Topotecan

BNF:

8.1.5

Status:

Do Not Prescribe (DNP)

Decision Date:

May 2016

Comments

DO NOT PRESCRIBE (DNP)6: NICE TA 389 - Topotecan is not recommended for treating recurrent platinum-resistant or platinum-refractory ovarian cancer. (Decision date  - May 2016)

Black Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

search again